Ratings by Jefferies (Glen Santangelo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2026 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 3/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2026 | GoodRx Holdings Inc. | GDRX | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2026 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 1/22/2026 | GoodRx Holdings Inc. | GDRX | Downgrade | Hold (Buy) |
2.60 (3.03) |
16.54% | Details | |
| 12/31/2025 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 6/12/2025 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2025 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 4/21/2025 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 4/11/2025 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 3/26/2025 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2025 | Phreesia Inc. | PHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2025 | ANI Pharmaceuticals | ANIP | New Coverage | Buy (N/A) |
63.26 (85.99) |
35.93% | Details | |
| 3/7/2025 | Viatris | VTRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2025 | Progyny | PGNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Waystar Holding | WAY | New Coverage | Buy (N/A) |
40.93 (23.81) |
-41.83% | Details | |
| 2/6/2025 | Bausch Health Companies | BHC | Downgrade | Hold (Buy) |
7.34 (4.91) |
-33.11% | Details | |
| 1/8/2025 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2025 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2024 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2024 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Progyny | PGNY | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Progyny | PGNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2024 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Amphastar Pharmaceuticals | AMPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2024 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 8/1/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2024 | R1 RCM Inc | RCM | Downgrade | Hold (Buy) |
12.88 (14.31) |
11.1% | Details | |
| 7/24/2024 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Viatris | VTRS | New Coverage | Buy (N/A) |
11.84 (16.96) |
43.24% | Details | |
| 6/13/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2024 | Collegium Pharmaceutical | COLL | Upgrade | Buy (Hold) |
31.71 (36.44) |
14.92% | Details | |
| 6/3/2024 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2024 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 5/20/2024 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 5/14/2024 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 4/16/2024 | Hims and Hers | HIMS | Downgrade | Hold (Buy) |
13.96 (36.17) |
159.1% | Details | |
| 4/11/2024 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Hims and Hers | HIMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Amphastar Pharmaceuticals | AMPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Teva Pharma | TEVA | Upgrade | Buy (Hold) |
11.18 (34.65) |
209.93% | Details | |
| 1/4/2024 | Collegium Pharmaceutical | COLL | Downgrade | Hold (Buy) |
31.23 (31.71) |
1.54% | Details | |
| 12/19/2023 | Elanco Animal Health | ELAN | New Coverage | Buy (N/A) |
13.76 (24.64) |
79.07% | Details | |
| 9/27/2023 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 9/20/2023 | Bausch Health Companies | BHC | Upgrade | Buy (Hold) |
8.37 (7.34) |
-12.31% | Details | |
| 7/25/2023 | Amphastar Pharmaceuticals | AMPH | New Coverage | Buy (N/A) |
60.68 (22.88) |
-62.29% | Details | |
| 6/16/2023 | R1 RCM Inc | RCM | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2023 | Progyny | PGNY | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Collegium Pharmaceutical | COLL | New Coverage | Buy (N/A) |
22.99 (36.44) |
58.5% | Details | |
| 3/22/2023 | Verrica Pharmaceuticals | VRCA | New Coverage | Buy (N/A) |
6.74 (6.07) |
-9.94% | Details | |
| 3/2/2023 | Amphastar Pharmaceuticals | AMPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2023 | Accolade Inc. | ACCD | Downgrade | Hold (Buy) |
12.53 (7.02) |
-43.97% | Details | |
| 2/9/2023 | Hims and Hers | HIMS | Upgrade | Buy (Hold) |
8.45 (36.17) |
328.05% | Details | |
| 1/27/2023 | Viatris | VTRS | Upgrade | Buy (Hold) |
11.64 (11.84) |
1.72% | Details | |
| 1/19/2023 | Teva Pharma | TEVA | Downgrade | Hold (Buy) |
10.84 (34.65) |
219.65% | Details | |
| 1/11/2023 | Accolade Inc. | ACCD | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Phreesia Inc. | PHR | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Definitive Healthcare Corp | DH | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2022 | Sol Gel Technologies Ltd. | SLGL | New Coverage | Hold (N/A) |
4.98 (78.44) |
1475.1% | Details | |
| 10/21/2022 | scPharmaceuticals | SCPH | New Coverage | Buy (N/A) |
5.29 (5.67) |
7.18% | Details | |
| 10/21/2022 | Optinose | OPTN | New Coverage | Buy (N/A) |
3.32 (9.60) |
189.16% | Details | |
| 10/21/2022 | Viatris | VTRS | New Coverage | Hold (N/A) |
9.38 (16.96) |
80.81% | Details | |
| 10/21/2022 | Pacira Pharmaceuticals | PCRX | New Coverage | Buy (N/A) |
53.04 (25.82) |
-51.32% | Details | |
| 10/21/2022 | Amphastar Pharmaceuticals | AMPH | New Coverage | Buy (N/A) |
29.23 (20.08) |
-31.3% | Details | |
| 10/21/2022 | Teva Pharma | TEVA | New Coverage | Buy (N/A) |
8.07 (34.65) |
329.37% | Details | |
| 10/21/2022 | Phathom Pharmaceuticals | PHAT | New Coverage | Buy (N/A) |
10.04 (11.55) |
15.04% | Details | |
| 10/21/2022 | Xeris Pharmaceuticals | XERS | New Coverage | Buy (N/A) |
1.23 (8.94) |
626.83% | Details | |
| 10/21/2022 | RVL Pharmaceuticals plc | RVLP | New Coverage | Hold (N/A) |
1.69 (0.03) |
-98.22% | Details | |
| 9/7/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Hims and Hers | HIMS | Maintain | Hold (N/A) |
|
Details | ||
| 7/21/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2022 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 6/28/2022 | R1 RCM Inc | RCM | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2022 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Tabula Rasa Healthcare | TRHC | Maintain | Hold (N/A) |
|
Details | ||
| 5/11/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2022 | Accolade Inc. | ACCD | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2022 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2022 | Phreesia Inc. | PHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2022 | Health Catalyst Inc. | HCAT | Upgrade | Buy (Hold) |
22.56 (2.27) |
-89.94% | Details | |
| 3/8/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Babylon Holdings | BBLN | Maintain | Hold (N/A) |
|
Details | ||
| 3/2/2022 | Progyny | PGNY | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2022 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 1/21/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2022 | Vocera Communications | VCRA | Downgrade | Hold (Buy) |
62.52 (79.13) |
26.57% | Details | |
| 1/5/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2021 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2021 | Babylon Holdings | BBLN | New Coverage | Hold (N/A) |
7.86 (0.55) |
-93% | Details | |
| 12/2/2021 | Accolade Inc. | ACCD | New Coverage | Buy (N/A) |
25.67 (7.02) |
-72.65% | Details | |
| 12/2/2021 | Health Catalyst Inc. | HCAT | New Coverage | Hold (N/A) |
43.39 (2.27) |
-94.77% | Details | |
| 12/2/2021 | Phreesia Inc. | PHR | New Coverage | Buy (N/A) |
57.68 (10.95) |
-81.02% | Details | |
| 12/2/2021 | Teladoc | TDOC | New Coverage | Hold (N/A) |
101.25 (9.52) |
-90.6% | Details | |
| 12/2/2021 | HealthEquity, Inc | HQY | New Coverage | Buy (N/A) |
54.68 (96.98) |
77.36% | Details | |
| 12/2/2021 | Progyny | PGNY | New Coverage | Buy (N/A) |
50.77 (30.78) |
-39.37% | Details | |
| 12/2/2021 | Vocera Communications | VCRA | New Coverage | Buy (N/A) |
58.34 (62.52) |
7.16% | Details | |
| 12/2/2021 | American Well Corp. | AMWL | New Coverage | Hold (N/A) |
6.50 (8.99) |
38.31% | Details | |
| 12/2/2021 | Doximity Inc | DOCS | New Coverage | Buy (N/A) |
67.65 (26.45) |
-60.9% | Details | |
| 12/2/2021 | Tabula Rasa Healthcare | TRHC | New Coverage | Hold (N/A) |
11.37 (10.50) |
-7.65% | Details | |
| 12/2/2021 | Hims and Hers | HIMS | New Coverage | Hold (N/A) |
6.55 (36.17) |
452.21% | Details | |
| 12/2/2021 | R1 RCM Inc | RCM | New Coverage | Buy (N/A) |
23.82 (12.88) |
-45.93% | Details | |
| 12/2/2021 | TalkSpace | TALK | New Coverage | Hold (N/A) |
2.29 (5.22) |
127.95% | Details | |
| 12/2/2021 | GoodRx Holdings Inc. | GDRX | New Coverage | Buy (N/A) |
39.92 (2.60) |
-93.49% | Details | |
| 12/2/2021 | Definitive Healthcare Corp | DH | New Coverage | Buy (N/A) |
29.31 (0.90) |
-96.93% | Details |
